Even with several U.S. states already legalizing marijuana in varying levels, there is still much debate about the supposed dangers and effects of cannabis. New research has yielded some interesting results pertaining to this case. Scientists built the most accurate 3D model of the brain’s receptors that are most responsible for the high that users get from the plant. Another study also found that instead of encouraging substance abuse, marijuana use could actually help combat addiction.
UT Southwestern Medical Center researchers built a 3D structure of the receptors in the brain that are responsible for binding with the chemicals found in cannabis that produces its signature high, and it is the most detailed one to date, MedicalXpress reports. The chemical in question is the tetrahydrocannabinol and the brain receptor that binds to it are the cannabinoid receptor 1.
By creating a 3D model of how these two factors interact and affect the brain’s chemistry, it becomes easier to understand the effects of marijuana on humans. More than that, looking into the receptors and the chemical’s effects on them also has potential benefits for other health issues according to the project’s lead Dr. Daniel Rosenbaum.
"What is most exciting from a therapeutic standpoint is that the same receptor pocket that binds THC also binds cannabinoid inhibitors that have been studied as possible treatments for conditions such as obesity," Dr. Rosenbaum said.
In related news, researchers submitted a paper to the Clinical Psychology Review suggesting that consumption of cannabis has potential benefits in combatting substance abuse, Medical News Today reports. The study was led by associate professor of psychology, Zach Walsh, from the University of British Columbia in Canada.
According to the study, cannabis can actually be an effective “Exit Drug” as opposed to the “Entry Drug” that it has always been viewed as. It can also have benefits related to mental illnesses, including PTSD and Alzheimer’s.


Why the future of marijuana legalization remains hazy despite high public support
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
CDC Monitors 41 Americans After Andes Hantavirus Outbreak on Luxury Cruise Ship
The four types of dementia most people don’t know exist
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 



